Cargando…

CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis

Transmembrane glycoprotein cluster of differentiation 36 (CD36) is a scavenger receptor class B protein (SR-B2) that serves various functions in lipid metabolism and signaling, in particular facilitating the cellular uptake of long-chain fatty acids. Recent studies have disclosed CD36 to play a prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Glatz, Jan F.C., Nabben, Miranda, Luiken, Joost J.F.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901000/
https://www.ncbi.nlm.nih.gov/pubmed/35125400
http://dx.doi.org/10.1097/MOL.0000000000000819
_version_ 1784664253902356480
author Glatz, Jan F.C.
Nabben, Miranda
Luiken, Joost J.F.P.
author_facet Glatz, Jan F.C.
Nabben, Miranda
Luiken, Joost J.F.P.
author_sort Glatz, Jan F.C.
collection PubMed
description Transmembrane glycoprotein cluster of differentiation 36 (CD36) is a scavenger receptor class B protein (SR-B2) that serves various functions in lipid metabolism and signaling, in particular facilitating the cellular uptake of long-chain fatty acids. Recent studies have disclosed CD36 to play a prominent regulatory role in cellular fatty acid metabolism in both health and disease. RECENT FINDINGS: The rate of cellular fatty acid uptake is short-term (i.e., minutes) regulated by the subcellular recycling of CD36 between endosomes and the plasma membrane. This recycling is governed by the activity of vacuolar-type H(+)-ATPase (v-ATPase) in the endosomal membrane via assembly and disassembly of two subcomplexes. The latter process is being influenced by metabolic substrates including fatty acids, glucose and specific amino acids, together resulting in a dynamic interplay to modify cellular substrate preference and uptake rates. Moreover, in cases of metabolic disease v-ATPase activity was found to be affected while interventions aimed at normalizing v-ATPase functioning had therapeutic potential. SUMMARY: The emerging central role of CD36 in cellular lipid homeostasis and recently obtained molecular insight in the interplay among metabolic substrates indicate the applicability of CD36 as target for metabolic modulation therapy in disease. Experimental studies already have shown the feasibility of this approach.
format Online
Article
Text
id pubmed-8901000
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89010002022-03-10 CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis Glatz, Jan F.C. Nabben, Miranda Luiken, Joost J.F.P. Curr Opin Lipidol GENETICS AND MOLECULAR BIOLOGY: Edited by Robert A. Hegele Transmembrane glycoprotein cluster of differentiation 36 (CD36) is a scavenger receptor class B protein (SR-B2) that serves various functions in lipid metabolism and signaling, in particular facilitating the cellular uptake of long-chain fatty acids. Recent studies have disclosed CD36 to play a prominent regulatory role in cellular fatty acid metabolism in both health and disease. RECENT FINDINGS: The rate of cellular fatty acid uptake is short-term (i.e., minutes) regulated by the subcellular recycling of CD36 between endosomes and the plasma membrane. This recycling is governed by the activity of vacuolar-type H(+)-ATPase (v-ATPase) in the endosomal membrane via assembly and disassembly of two subcomplexes. The latter process is being influenced by metabolic substrates including fatty acids, glucose and specific amino acids, together resulting in a dynamic interplay to modify cellular substrate preference and uptake rates. Moreover, in cases of metabolic disease v-ATPase activity was found to be affected while interventions aimed at normalizing v-ATPase functioning had therapeutic potential. SUMMARY: The emerging central role of CD36 in cellular lipid homeostasis and recently obtained molecular insight in the interplay among metabolic substrates indicate the applicability of CD36 as target for metabolic modulation therapy in disease. Experimental studies already have shown the feasibility of this approach. Lippincott Williams & Wilkins 2022-04 2022-02-03 /pmc/articles/PMC8901000/ /pubmed/35125400 http://dx.doi.org/10.1097/MOL.0000000000000819 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle GENETICS AND MOLECULAR BIOLOGY: Edited by Robert A. Hegele
Glatz, Jan F.C.
Nabben, Miranda
Luiken, Joost J.F.P.
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
title CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
title_full CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
title_fullStr CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
title_full_unstemmed CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
title_short CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
title_sort cd36 (sr-b2) as master regulator of cellular fatty acid homeostasis
topic GENETICS AND MOLECULAR BIOLOGY: Edited by Robert A. Hegele
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901000/
https://www.ncbi.nlm.nih.gov/pubmed/35125400
http://dx.doi.org/10.1097/MOL.0000000000000819
work_keys_str_mv AT glatzjanfc cd36srb2asmasterregulatorofcellularfattyacidhomeostasis
AT nabbenmiranda cd36srb2asmasterregulatorofcellularfattyacidhomeostasis
AT luikenjoostjfp cd36srb2asmasterregulatorofcellularfattyacidhomeostasis